Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: A4IAY2
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 6 |
GO:0006644 | phospholipid metabolic process | 4 | 6 |
GO:0006793 | phosphorus metabolic process | 3 | 6 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 6 |
GO:0008152 | metabolic process | 1 | 6 |
GO:0008610 | lipid biosynthetic process | 4 | 6 |
GO:0008654 | phospholipid biosynthetic process | 5 | 6 |
GO:0009058 | biosynthetic process | 2 | 6 |
GO:0009987 | cellular process | 1 | 6 |
GO:0019637 | organophosphate metabolic process | 3 | 6 |
GO:0044237 | cellular metabolic process | 2 | 6 |
GO:0044238 | primary metabolic process | 2 | 6 |
GO:0044255 | cellular lipid metabolic process | 3 | 6 |
GO:0071704 | organic substance metabolic process | 2 | 6 |
GO:0090407 | organophosphate biosynthetic process | 4 | 6 |
GO:1901576 | organic substance biosynthetic process | 3 | 6 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 1 |
GO:0006656 | phosphatidylcholine biosynthetic process | 5 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 1 |
GO:0046470 | phosphatidylcholine metabolic process | 4 | 1 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 1 |
GO:0046486 | glycerolipid metabolic process | 4 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 6 |
GO:0016740 | transferase activity | 2 | 6 |
GO:0016746 | acyltransferase activity | 3 | 6 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 110 | 112 | PF00675 | 0.731 |
CLV_NRD_NRD_1 | 216 | 218 | PF00675 | 0.414 |
CLV_NRD_NRD_1 | 320 | 322 | PF00675 | 0.478 |
CLV_NRD_NRD_1 | 350 | 352 | PF00675 | 0.495 |
CLV_NRD_NRD_1 | 417 | 419 | PF00675 | 0.510 |
CLV_PCSK_KEX2_1 | 110 | 112 | PF00082 | 0.731 |
CLV_PCSK_KEX2_1 | 216 | 218 | PF00082 | 0.414 |
CLV_PCSK_KEX2_1 | 320 | 322 | PF00082 | 0.478 |
CLV_PCSK_KEX2_1 | 350 | 352 | PF00082 | 0.495 |
CLV_PCSK_KEX2_1 | 360 | 362 | PF00082 | 0.393 |
CLV_PCSK_KEX2_1 | 504 | 506 | PF00082 | 0.392 |
CLV_PCSK_PC1ET2_1 | 360 | 362 | PF00082 | 0.511 |
CLV_PCSK_PC1ET2_1 | 504 | 506 | PF00082 | 0.391 |
CLV_PCSK_SKI1_1 | 101 | 105 | PF00082 | 0.738 |
CLV_PCSK_SKI1_1 | 180 | 184 | PF00082 | 0.343 |
CLV_PCSK_SKI1_1 | 210 | 214 | PF00082 | 0.389 |
CLV_PCSK_SKI1_1 | 321 | 325 | PF00082 | 0.467 |
CLV_PCSK_SKI1_1 | 361 | 365 | PF00082 | 0.501 |
CLV_PCSK_SKI1_1 | 419 | 423 | PF00082 | 0.381 |
CLV_PCSK_SKI1_1 | 424 | 428 | PF00082 | 0.379 |
DOC_MAPK_gen_1 | 124 | 133 | PF00069 | 0.518 |
DOC_MAPK_gen_1 | 367 | 375 | PF00069 | 0.665 |
DOC_MAPK_MEF2A_6 | 127 | 135 | PF00069 | 0.455 |
DOC_PP1_RVXF_1 | 328 | 334 | PF00149 | 0.670 |
DOC_PP2B_LxvP_1 | 117 | 120 | PF13499 | 0.542 |
DOC_USP7_MATH_1 | 385 | 389 | PF00917 | 0.733 |
DOC_USP7_MATH_1 | 390 | 394 | PF00917 | 0.753 |
DOC_USP7_MATH_1 | 514 | 518 | PF00917 | 0.592 |
DOC_USP7_UBL2_3 | 360 | 364 | PF12436 | 0.708 |
DOC_USP7_UBL2_3 | 493 | 497 | PF12436 | 0.698 |
DOC_WW_Pin1_4 | 104 | 109 | PF00397 | 0.593 |
DOC_WW_Pin1_4 | 396 | 401 | PF00397 | 0.682 |
LIG_14-3-3_CanoR_1 | 190 | 198 | PF00244 | 0.657 |
LIG_14-3-3_CanoR_1 | 210 | 219 | PF00244 | 0.587 |
LIG_14-3-3_CanoR_1 | 279 | 285 | PF00244 | 0.740 |
LIG_14-3-3_CanoR_1 | 320 | 326 | PF00244 | 0.680 |
LIG_14-3-3_CanoR_1 | 403 | 408 | PF00244 | 0.683 |
LIG_14-3-3_CanoR_1 | 433 | 439 | PF00244 | 0.679 |
LIG_Actin_WH2_2 | 281 | 298 | PF00022 | 0.744 |
LIG_APCC_ABBA_1 | 426 | 431 | PF00400 | 0.694 |
LIG_BRCT_BRCA1_1 | 156 | 160 | PF00533 | 0.380 |
LIG_BRCT_BRCA1_1 | 454 | 458 | PF00533 | 0.452 |
LIG_FHA_1 | 301 | 307 | PF00498 | 0.736 |
LIG_FHA_2 | 148 | 154 | PF00498 | 0.498 |
LIG_FHA_2 | 343 | 349 | PF00498 | 0.683 |
LIG_FHA_2 | 379 | 385 | PF00498 | 0.745 |
LIG_IRF3_LxIS_1 | 131 | 136 | PF10401 | 0.434 |
LIG_LIR_Apic_2 | 97 | 102 | PF02991 | 0.579 |
LIG_LIR_Gen_1 | 112 | 122 | PF02991 | 0.482 |
LIG_LIR_Gen_1 | 136 | 145 | PF02991 | 0.483 |
LIG_LIR_Gen_1 | 156 | 166 | PF02991 | 0.199 |
LIG_LIR_Gen_1 | 187 | 196 | PF02991 | 0.636 |
LIG_LIR_Gen_1 | 282 | 290 | PF02991 | 0.752 |
LIG_LIR_Gen_1 | 35 | 44 | PF02991 | 0.530 |
LIG_LIR_Gen_1 | 371 | 378 | PF02991 | 0.695 |
LIG_LIR_Gen_1 | 455 | 466 | PF02991 | 0.489 |
LIG_LIR_Nem_3 | 112 | 117 | PF02991 | 0.422 |
LIG_LIR_Nem_3 | 129 | 135 | PF02991 | 0.348 |
LIG_LIR_Nem_3 | 136 | 140 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 156 | 161 | PF02991 | 0.199 |
LIG_LIR_Nem_3 | 168 | 172 | PF02991 | 0.331 |
LIG_LIR_Nem_3 | 18 | 24 | PF02991 | 0.530 |
LIG_LIR_Nem_3 | 192 | 198 | PF02991 | 0.652 |
LIG_LIR_Nem_3 | 282 | 288 | PF02991 | 0.758 |
LIG_LIR_Nem_3 | 324 | 328 | PF02991 | 0.633 |
LIG_LIR_Nem_3 | 35 | 39 | PF02991 | 0.249 |
LIG_LIR_Nem_3 | 371 | 375 | PF02991 | 0.694 |
LIG_LIR_Nem_3 | 453 | 459 | PF02991 | 0.532 |
LIG_LIR_Nem_3 | 97 | 103 | PF02991 | 0.543 |
LIG_LYPXL_yS_3 | 456 | 459 | PF13949 | 0.530 |
LIG_PCNA_yPIPBox_3 | 236 | 246 | PF02747 | 0.718 |
LIG_PCNA_yPIPBox_3 | 41 | 51 | PF02747 | 0.530 |
LIG_Pex14_1 | 339 | 343 | PF04695 | 0.669 |
LIG_Pex14_1 | 74 | 78 | PF04695 | 0.508 |
LIG_Pex14_2 | 158 | 162 | PF04695 | 0.530 |
LIG_Pex14_2 | 342 | 346 | PF04695 | 0.681 |
LIG_Pex14_2 | 425 | 429 | PF04695 | 0.689 |
LIG_SH2_CRK | 285 | 289 | PF00017 | 0.613 |
LIG_SH2_CRK | 312 | 316 | PF00017 | 0.722 |
LIG_SH2_CRK | 325 | 329 | PF00017 | 0.668 |
LIG_SH2_GRB2like | 228 | 231 | PF00017 | 0.664 |
LIG_SH2_NCK_1 | 228 | 232 | PF00017 | 0.715 |
LIG_SH2_SRC | 132 | 135 | PF00017 | 0.491 |
LIG_SH2_SRC | 228 | 231 | PF00017 | 0.719 |
LIG_SH2_STAT3 | 24 | 27 | PF00017 | 0.636 |
LIG_SH2_STAT5 | 132 | 135 | PF00017 | 0.491 |
LIG_SH2_STAT5 | 144 | 147 | PF00017 | 0.351 |
LIG_SH2_STAT5 | 195 | 198 | PF00017 | 0.652 |
LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.331 |
LIG_SH2_STAT5 | 31 | 34 | PF00017 | 0.531 |
LIG_SH2_STAT5 | 36 | 39 | PF00017 | 0.301 |
LIG_SH2_STAT5 | 9 | 12 | PF00017 | 0.530 |
LIG_SH3_3 | 128 | 134 | PF00018 | 0.496 |
LIG_TYR_ITIM | 29 | 34 | PF00017 | 0.580 |
LIG_TYR_ITIM | 323 | 328 | PF00017 | 0.669 |
LIG_UBA3_1 | 13 | 20 | PF00899 | 0.516 |
LIG_WRC_WIRS_1 | 155 | 160 | PF05994 | 0.435 |
LIG_WRC_WIRS_1 | 185 | 190 | PF05994 | 0.636 |
LIG_WRC_WIRS_1 | 343 | 348 | PF05994 | 0.678 |
MOD_CDK_SPxK_1 | 104 | 110 | PF00069 | 0.593 |
MOD_CDK_SPxxK_3 | 104 | 111 | PF00069 | 0.538 |
MOD_CDK_SPxxK_3 | 396 | 403 | PF00069 | 0.686 |
MOD_CK1_1 | 241 | 247 | PF00069 | 0.610 |
MOD_CK1_1 | 257 | 263 | PF00069 | 0.613 |
MOD_CK1_1 | 283 | 289 | PF00069 | 0.697 |
MOD_CK1_1 | 80 | 86 | PF00069 | 0.408 |
MOD_CK2_1 | 147 | 153 | PF00069 | 0.504 |
MOD_CK2_1 | 342 | 348 | PF00069 | 0.680 |
MOD_CK2_1 | 374 | 380 | PF00069 | 0.671 |
MOD_CK2_1 | 396 | 402 | PF00069 | 0.692 |
MOD_Cter_Amidation | 416 | 419 | PF01082 | 0.515 |
MOD_GlcNHglycan | 213 | 216 | PF01048 | 0.452 |
MOD_GlcNHglycan | 376 | 379 | PF01048 | 0.478 |
MOD_GlcNHglycan | 387 | 390 | PF01048 | 0.402 |
MOD_GlcNHglycan | 467 | 470 | PF01048 | 0.664 |
MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.662 |
MOD_GSK3_1 | 254 | 261 | PF00069 | 0.661 |
MOD_GSK3_1 | 265 | 272 | PF00069 | 0.628 |
MOD_GSK3_1 | 279 | 286 | PF00069 | 0.740 |
MOD_GSK3_1 | 374 | 381 | PF00069 | 0.686 |
MOD_GSK3_1 | 519 | 526 | PF00069 | 0.612 |
MOD_N-GLC_1 | 229 | 234 | PF02516 | 0.462 |
MOD_N-GLC_1 | 238 | 243 | PF02516 | 0.378 |
MOD_N-GLC_1 | 254 | 259 | PF02516 | 0.367 |
MOD_N-GLC_1 | 265 | 270 | PF02516 | 0.447 |
MOD_N-GLC_1 | 80 | 85 | PF02516 | 0.766 |
MOD_N-GLC_1 | 95 | 100 | PF02516 | 0.600 |
MOD_NEK2_1 | 160 | 165 | PF00069 | 0.510 |
MOD_NEK2_1 | 211 | 216 | PF00069 | 0.584 |
MOD_NEK2_1 | 238 | 243 | PF00069 | 0.675 |
MOD_NEK2_1 | 280 | 285 | PF00069 | 0.714 |
MOD_NEK2_1 | 295 | 300 | PF00069 | 0.555 |
MOD_NEK2_1 | 342 | 347 | PF00069 | 0.678 |
MOD_NEK2_1 | 39 | 44 | PF00069 | 0.530 |
MOD_NEK2_1 | 450 | 455 | PF00069 | 0.408 |
MOD_NEK2_1 | 498 | 503 | PF00069 | 0.637 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.529 |
MOD_PIKK_1 | 295 | 301 | PF00454 | 0.730 |
MOD_PKA_1 | 110 | 116 | PF00069 | 0.514 |
MOD_PKA_2 | 110 | 116 | PF00069 | 0.514 |
MOD_PKA_2 | 189 | 195 | PF00069 | 0.636 |
MOD_PKA_2 | 295 | 301 | PF00069 | 0.730 |
MOD_PKA_2 | 402 | 408 | PF00069 | 0.726 |
MOD_Plk_1 | 238 | 244 | PF00069 | 0.661 |
MOD_Plk_1 | 95 | 101 | PF00069 | 0.553 |
MOD_Plk_2-3 | 218 | 224 | PF00069 | 0.731 |
MOD_Plk_4 | 154 | 160 | PF00069 | 0.435 |
MOD_Plk_4 | 202 | 208 | PF00069 | 0.654 |
MOD_Plk_4 | 241 | 247 | PF00069 | 0.711 |
MOD_Plk_4 | 248 | 254 | PF00069 | 0.670 |
MOD_Plk_4 | 280 | 286 | PF00069 | 0.684 |
MOD_Plk_4 | 39 | 45 | PF00069 | 0.452 |
MOD_Plk_4 | 434 | 440 | PF00069 | 0.682 |
MOD_Plk_4 | 95 | 101 | PF00069 | 0.511 |
MOD_ProDKin_1 | 104 | 110 | PF00069 | 0.593 |
MOD_ProDKin_1 | 396 | 402 | PF00069 | 0.681 |
MOD_SUMO_for_1 | 363 | 366 | PF00179 | 0.700 |
TRG_DiLeu_BaLyEn_6 | 113 | 118 | PF01217 | 0.556 |
TRG_DiLeu_BaLyEn_6 | 276 | 281 | PF01217 | 0.780 |
TRG_ENDOCYTIC_2 | 132 | 135 | PF00928 | 0.491 |
TRG_ENDOCYTIC_2 | 195 | 198 | PF00928 | 0.652 |
TRG_ENDOCYTIC_2 | 228 | 231 | PF00928 | 0.719 |
TRG_ENDOCYTIC_2 | 285 | 288 | PF00928 | 0.694 |
TRG_ENDOCYTIC_2 | 31 | 34 | PF00928 | 0.602 |
TRG_ENDOCYTIC_2 | 312 | 315 | PF00928 | 0.731 |
TRG_ENDOCYTIC_2 | 325 | 328 | PF00928 | 0.565 |
TRG_ENDOCYTIC_2 | 343 | 346 | PF00928 | 0.649 |
TRG_ENDOCYTIC_2 | 36 | 39 | PF00928 | 0.401 |
TRG_ENDOCYTIC_2 | 407 | 410 | PF00928 | 0.610 |
TRG_ENDOCYTIC_2 | 456 | 459 | PF00928 | 0.530 |
TRG_ER_diArg_1 | 109 | 111 | PF00400 | 0.536 |
TRG_ER_diArg_1 | 319 | 321 | PF00400 | 0.676 |
TRG_ER_diArg_1 | 349 | 351 | PF00400 | 0.696 |
TRG_Pf-PMV_PEXEL_1 | 73 | 77 | PF00026 | 0.680 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S7X8X9 | Leishmania donovani | 100% | 100% |
A4HMB6 | Leishmania braziliensis | 82% | 100% |
E9AER0 | Leishmania major | 95% | 100% |
E9B5W5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |